Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • Page (6)
  • Blog post (5)
  • News item (5)

Publication date

Selecting an option will change the focus to the start of the list.
  • (-) March 2024 (10)
  • (-) February 2022 (7)
  • April 2026 (11)
  • March 2026 (19)
  • February 2026 (8)
  • January 2026 (9)
  • December 2025 (21)
  • November 2025 (16)
  • October 2025 (11)
  • September 2025 (19)
  • August 2025 (9)
  • July 2025 (7)
  • June 2025 (8)
  • May 2025 (4)
  • April 2025 (9)
  • March 2025 (3)
  • February 2025 (6)
  • January 2025 (20)
  • December 2024 (13)
  • November 2024 (7)
  • October 2024 (10)
  • September 2024 (7)
  • August 2024 (5)
  • July 2024 (12)
  • June 2024 (7)
  • May 2024 (9)
  • April 2024 (20)
  • February 2024 (7)
  • January 2024 (3)
  • December 2023 (15)
  • November 2023 (6)
  • October 2023 (10)
  • September 2023 (17)
  • August 2023 (4)
  • July 2023 (13)
  • June 2023 (19)
  • May 2023 (4)
  • April 2023 (15)
  • March 2023 (20)
  • February 2023 (20)
  • January 2023 (10)
  • December 2022 (14)
  • November 2022 (25)
  • October 2022 (18)
  • September 2022 (11)
  • August 2022 (10)
  • July 2022 (18)
  • June 2022 (17)
  • May 2022 (10)
  • April 2022 (6)
  • March 2022 (9)
  • January 2022 (4)
  • December 2021 (17)
  • November 2021 (9)
  • October 2021 (9)
  • September 2021 (9)
  • August 2021 (6)
  • July 2021 (18)
  • June 2021 (14)
  • May 2021 (15)
  • April 2021 (15)
  • March 2021 (12)
  • February 2021 (12)
  • January 2021 (7)
  • December 2020 (11)
  • November 2020 (5)
  • October 2020 (9)
  • September 2020 (3)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (9)
  • May 2020 (10)
  • April 2020 (10)
  • March 2020 (8)
  • February 2020 (10)
  • January 2020 (6)
  • December 2019 (4)
  • November 2019 (5)
  • October 2019 (11)
  • September 2019 (4)
  • August 2019 (12)
  • July 2019 (4)
  • June 2019 (9)
  • May 2019 (13)
  • April 2019 (8)
  • March 2019 (5)
  • February 2019 (9)
  • January 2019 (10)
  • December 2018 (5)
  • November 2018 (15)
  • October 2018 (12)
  • September 2018 (2)
  • August 2018 (5)
  • July 2018 (6)
  • May 2018 (4)
  • April 2018 (1)
  • March 2018 (5)
  • February 2018 (4)
  • January 2018 (2)
  • December 2017 (12)
  • November 2017 (2)
  • October 2017 (6)
  • September 2017 (12)
  • August 2017 (7)
  • July 2017 (5)
  • June 2017 (1)
  • May 2017 (2)
  • April 2017 (2)
  • March 2017 (4)
  • February 2017 (3)
  • January 2017 (4)
  • December 2016 (8)
  • November 2016 (2)
  • October 2016 (7)
  • August 2016 (1)
  • July 2016 (1)
  • June 2016 (2)
  • March 2016 (15)
  • February 2016 (1)
  • January 2016 (6)
  • December 2015 (7)
  • November 2015 (5)
  • October 2015 (2)
  • August 2015 (1)
  • July 2015 (7)
  • June 2015 (2)
  • May 2015 (1)
  • April 2015 (5)
  • March 2015 (14)
  • February 2015 (4)
  • January 2015 (1)
  • October 2014 (3)
  • August 2014 (3)
  • July 2014 (1)
  • June 2014 (4)
  • May 2014 (1)
  • April 2014 (7)
  • March 2014 (3)
  • February 2014 (10)
  • December 2013 (9)
  • November 2013 (3)
  • October 2013 (1)
  • September 2013 (2)
  • August 2013 (2)
  • July 2013 (2)
  • May 2013 (1)
  • March 2013 (2)
  • December 2012 (1)
  • November 2012 (5)
  • October 2012 (2)
  • July 2012 (5)
  • April 2012 (2)
  • March 2012 (1)
  • February 2012 (8)
  • January 2012 (11)
  • December 2011 (8)
  • September 2011 (6)
  • June 2011 (1)
  • May 2011 (1)
  • March 2011 (2)
  • January 2011 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • Nanotechnology and advanced materials (5)
  • COVID-19 (3)
  • International (3)
  • Alternatives to animal testing (1)
  • Infectious Disease Control (1)
  • Nitrogen (1)
  • Population screening programs in the Caribbean Netherlands (1)

17 search results

You searched for these word(s): risk assessment
  • AI for chemical risk assessment: promises and concerns

    https://www.rivm.nl/en/weblog/ai-for-chemical-risk-assessment-promises-and-concerns

    … increasing and has the potential to revolutionize chemical risk assessment. For predicting the toxicity of … asked about their views on the use of AI for chemical risk assessment.  Revolutionizing risk assessment with AI: predicting toxicity without animal … AI for chemical risk assessment: promises and concerns …

    Publication date: 03-26-2024
  • Landscape New Approach Methodologies (NAMs) for the safety assessment of pharmaceutical products

    https://www.rivm.nl/en/alternatives-to-animal-testing/landscape-nams/safety-assessment-pharmaceutical-products

    … (NAMs) can reduce animal testing for the safety assessment of pharmaceutical products. However, implementing … Landscape New Approach Methodologies (NAMs) for the safety assessment of pharmaceutical products …

    Publication date: 03-25-2024
  • RIVM advises against using products containing the herbs Huperzia serrata, Tabernanthe iboga or Ashwagandha

    https://www.rivm.nl/en/news/rivm-advises-against-using-products-containing-herbs-huperzia-serrata-tabernanthe-iboga-or

    … can be harmful to health. RIVM has identified the risks of these herbs and advises consumers, and especially …

    Publication date: 03-08-2024
  • Following up on lessons learned from graphene flagship

    https://www.rivm.nl/en/weblog/following-up-on-lessons-learned-from-graphene-flagship

    … the EU Graphene Flagship have highlighted the complexity of assessing the safety of graphene and related materials. Such assessment requires detailed knowledge of safety-related … chemicals regulation REACH. This may also allow safety assessment of graphene and related materials. The …

    Publication date: 03-26-2024
  • Nitrogen and nature approach shows progress towards 2030, but targets are out of reach

    https://www.rivm.nl/en/news/nitrogen-and-nature-approach-shows-progress-towards-2030-but-targets-are-out-of-reach

    … shown by a study conducted by PBL Netherlands Environmental Assessment Agency, Wageningen University & Research and … the amount of nitrogen deposition above which nature is at risk of being damaged. A quarter of the decrease can be … study on the website of the PBL Netherlands Environmental Assessment Agency.   …

    Publication date: 03-04-2024
  • Booster vaccination prevents many hospital and ICU admissions

    https://www.rivm.nl/en/news/booster-vaccination-prevents-many-hospital-and-ICU-admissions

    … by the Omicron variant of the coronavirus SARS-CoV-2. The risk of hospital admission after a booster vaccination was … vaccination with the basic series without a booster, the risk of hospital admission was more than 2 times lower than … against ICU admission, but to a lesser extent: 74%. The risk of ICU admission after a booster vaccination was more …

    Publication date: 02-15-2022
  • COVID-19 recommendations for vulnerable groups of people

    https://www.rivm.nl/en/coronavirus-covid-19/risk-groups/recommendations-for-vulnerable-groups-of-people

    … Some groups of people have a higher risk of severe illness resulting from the coronavirus … They are particularly vulnerable.  People who are at higher risk can take their own measures to protect themselves, … vaccination against COVID-19. People who have a higher risk of severe COVID-19 resulting from a health condition or …

    Publication date: 02-17-2022
  • WHO Reference Laboratory for Coronaviruses

    https://www.rivm.nl/en/infectious-disease-control/who-reference-laboratory-coronaviruses

    … Preparedness and Response to High Threat Pathogens and Biorisk and the WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water . The World Health …

    Publication date: 03-28-2024
  • FAQ about cervical cancer screening on Sint Eustatius

    https://www.rivm.nl/en/population-screening-caribbean-netherlands/st-eustatius/cervical-cancer/faq

    … contact, there is little chance of HPV infection. The risk of a precancerous stage or cervical cancer is then very … on the hands and in the mouth. . You can reduce your risk of developing HPV infections by: Using a latex condom, … If I have HPV, what is the risk of cervical cancer? …

    Publication date: 02-02-2022
  • Food products from outside the EU still can contain titanium dioxide (E 171)

    https://www.rivm.nl/en/weblog/food-products-from-outside-eu-still-can-contain-titanium-dioxide-e-171

    … that there is no solid evidence that E 171 poses a health risk. While they acknowledge uncertainties about its … and potential health outcomes.  Uncertainties inherent to risk assessment Apart from the different assumptions mentioned …

    Publication date: 03-26-2024
  • The role of RIVM in COVID-19 testing

    https://www.rivm.nl/en/coronavirus-covid-19/testing/rivm-role

    … report 2 , supplementary LCI guidelines ). In these quality assessments, laboratories demonstrate how good their test … detect and control the virus) by means of external quality assessment . Finally, RIVM is researching how well you are …

    Publication date: 02-24-2022
  • SCCS raises concern over the safety of fullerenes in cosmetic products

    https://www.rivm.nl/en/weblog/sccs-raises-concern-over-safety-of-fullerenes-in-cosmetic-products

    … the Cosmetic Regulation ((EC) No. 1223/2009 ).  Safety assessment by SCCS  The European Commission (EC) is … nanomaterials that are of concern and must undergo a safety assessment. If the data is insufficient, the EC must ban …

    Publication date: 03-26-2024
  • Collaboration and funding are critical in the development of test methods

    https://www.rivm.nl/en/weblog/collaboration-and-funding-are-critical-in-development-of-test-methods

    … member countries to accept each other’s data for safety assessments of chemicals and materials, as long as the …

    Publication date: 03-26-2024
  • Landscape New Approach Methodologies (NAMs) safety assessment pharmaceutical products

    https://www.rivm.nl/en/documenten/landscape-new-approach-methodologies-nams-safety-assessment-pharmaceutical-products

    … Landscape NAMs safety assessment pharmaceutical products. Towards the future of … Landscape New Approach Methodologies (NAMs) safety assessment pharmaceutical products …

    Publication date: 03-25-2024
  • Key publications on Life Course and Health

    https://www.rivm.nl/en/who-collaborating-centre-life-course-and-health/key-publications

    … converge at midlife without increased cardiometabolic risk. Ibi D, Rietman ML, Picavet HSJ, van Klinken JB, van … Epub 2016 Feb 17. Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of …

    Publication date: 02-24-2022
  • Boosters improve diminished protection against Omicron infection after basic COVID-19 vaccination or previous infection

    https://www.rivm.nl/en/news/boosters-improve-diminished-protection-against-omicron-infection-after-basic-covid-19

    … The risk of COVID-19 from the Delta variant was 76% lower after … vaccination and booster vaccination, you have a much lower risk of becoming seriously ill. If you have symptoms, stay …

    Publication date: 02-08-2022
  • People aged 70 and up invited for repeat vaccination against COVID-19

    https://www.rivm.nl/en/news/people-aged-70-and-up-invited-for-repeat-vaccination-against-covid-19

    … People over 70 have a higher risk of becoming seriously ill from an infection with the … severely impaired immunity. These groups also have a higher risk of serious illness if they are infected with the …

    Publication date: 02-25-2022

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon